Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Jun 15, 2021; 13(6): 612-624
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.612
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.612
Table 2 Follow up time, endoscopic findings and symptoms of patients’ cohort
| n | % | |
| Total | 43 | |
| Follow up time (d) | Mean 790 (median 574) | Range 106-3640 |
| Mucosal disease | ||
| Reflux esophagitis | ||
| None | 18 | 42 |
| LA grade A | 9 | 21 |
| LA Grade B | 7 | 16 |
| LA Grade C | 5 | 12 |
| LA Grade D | 4 | 9 |
| Barrett’s | 1 | 2 |
| Symptoms | ||
| Heartburn | 32 | 74 |
| Regurgitation | 36 | 84 |
| Dysphagia | 20 | 47 |
| Chest pain | 25 | 58 |
| Atypical symptoms | 10 | 23 |
| Weight loss | 20 | 47 |
- Citation: Babic B, Müller DT, Gebauer F, Schiffmann LM, Datta RR, Schröder W, Bruns CJ, Leers JM, Fuchs HF. Gastrointestinal function testing model using a new laryngopharyngeal pH probe (Restech) in patients after Ivor-Lewis esophagectomy. World J Gastrointest Oncol 2021; 13(6): 612-624
- URL: https://www.wjgnet.com/1948-5204/full/v13/i6/612.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i6.612